MIS-C across three SARS-CoV-2 variants: Changes in COVID-19 testing and clinical characteristics in a cohort of U.S. children
Jessica Laird(Boston Children's Hospital), Jane W. Newburger(Oregon Health & Science University), Numaira Khan(Boston Children's Hospital), Sarah D. de Ferranti, Francesca Sperotto(Brigham and Women's Hospital), Kevin G. Friedman(Boston Children's Hospital), Kimberlee Gauvreau(Boston Children's Hospital), Annette Baker(Boston Children's Hospital), Megan Day‐Lewis(Boston Children's Hospital), Mary Beth F. Son(Boston Children's Hospital), Simran Mahanta(Boston Children's Hospital), Audrey Dionne(Boston Children's Hospital)
Cited by 14
Related Papers
Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
|Circulation|2018|7.2k
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
|Circulation|2017|3.7k
Prevention of Infective Endocarditis
|Circulation|2007|2.8k
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
|New England Journal of Medicine|2020|2.7k